Healthcare
Omnes et al. in €4m series-A round for Horama
Fresh funds will help the biotechnology researcher develop two products
GHO buys Nicox and Visufarma
Newco will hold a combined portfolio of 60 products worldwide
Carlyle buys minority stake in Schön clinic group
Deal values Schön Klinik, which has 17 locations across Germany, at €1.5bn
Affiris raises €10m from MIG et al.
Affiris has raised €130m of funding to date, of which half comes from licences and grants
Imperial, Cambridge Innovation in £12m Storm series-A
Cambridge-based biotech will explore potential new cancer therapies
New Leaf backs Crispr's $38m boost to series-B
Closing comes a week after US regulators approved Crispr's first clinical trial
Altor exceeds 25% IRR on Ferrosan Medical Devices exit
Final exit comes five years after GP divested Ferrosan Consumer Health division to Pfizer
Panakés and Invitalia lead €4m series-A for Echolight
Deal marks the fifth investment for Invitalia Ventures and the first for Panakés
SHS invests in Tyromotion
SHS's first investment in Austria follows a collaboration agreement with AWS
Epidarex leads £4.3m series-A for Mironid
Backers include existing investors Scottish Enterprise and the University of Strathclyde
Advent, Sunstone et al. in $60m round for F2G
Growth investment is F2G's seventh and largest-ever round of funding
Summit's DentalPro bolts on Giovanni Bona for €80m
Pemberton supported the acquisition with a €70m bond facility
Argos Soditic reaps 3x return on Cisbio Bioassays exit
Secondary buyout marks new owner Abenex's 60th investment in France
Delos leads Allecra Therapeutics' €22m round
Startup received funding from Forbion's main fund and its latest co-investment fund
HgCapital exits Mainio Vire to Triton's Mehiläinen
Exit typifies current high demand for healthcare assets in the Nordic market
Newronika raises €1.7m from Innogest et al.
Venture capital backers include Italian firms Atlante Ventures and F3F
Ufenau buys Doktorhuus
Ufenau plans to apply a buy-and-build strategy in the Swiss medical practice market
Altor exits Curato to Aleris
Sale comes three years after the GP acquired the radiology clinic group in an SBO from CapMan
Genesis buys Quinta-Analytica
Buyout marks the first deal for the €80m Genesis Private Equity Fund III fund
MTIP in ReActive series-A
Further investors in the round included High-Tech Gründerfonds, Bayern Kapital and TQ-Group
LDC exits Synexus to PPD in £178m deal
Sale provides the GP with a 2.3x return after just a one-year tenure
CM-CIC leads €6m in series-A for InFlectis BioScience
CM-CIC and Regimes Ventures joins previous pool of investors including Go Capital
IK realises Attendo investment with SEK 1.91bn share sale
Mid-market GP brings ownership of care services business to an end 10 years after acquisition
Maj Invest exits Medicom IP in trade sale
GP sells pre-crisis investment in Danish medical devices company after nine-year holding period